Literature DB >> 28810096

Point-Counterpoint: CYP2C19 Genotyping for Clopidogrel.

Eric A Larson1, Nathan J Miller1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28810096

Source DB:  PubMed          Journal:  S D Med        ISSN: 0038-3317


× No keyword cloud information.
  2 in total

1.  Point-Counterpoint: SLCO1B1 Genotyping for Statins.

Authors:  Russell A Wilke; Joseph Fanciullo
Journal:  S D Med       Date:  2017-03

2.  Effects of different CYP2C19 genotypes on prognosis of patients complicated with atrial fibrillation taking clopidogrel after PCI.

Authors:  Qifeng Zhang; Zhixiong Zhong; Bin Li; Zhengxian Liao; Pingsen Zhao; Zhuolian Ye; Xuebo He; Hao Wang; Wenhao Chen; Junping Huang
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.